Commodore-Capital-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "NUVL",
  "CNTA",
  "ALKS",
  "ORIC",
  "TYRA",
  "NRIX",
  "MNMD",
  "PHVS",
  "NGNE",
  "AVTX",
  null,
  "SRRK",
  "SYRE",
  "APGE",
  "IKT",
  null,
  "AGIO",
  "SLDB",
  "SLNO",
  "COGT",
  "ELVN",
  "VTGN",
  "VRDN",
  "XENE",
  "ORKA",
  "VERA",
  "PCVX",
  "CRDF",
  "CELC",
  "CLDX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 31
Total Value: 1357083846
Accession Number: 0001831942-25-000005
Form Type: 13F-HR
CIK: commodore-capital-lp
Manager Name: Commodore-Capital-Lp

Data Enrichment

94% identified

29 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

31 positions • $1.4B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

Cardiff Oncology, Inc.

CRDF|14147L108

Shares:5.4M

Value:$16.9M

% of Portfolio:1.2% ($16.9M/$1.4B)

Oruka Therapeutics, Inc.

ORKA|687604108

Shares:1.4M

Value:$14.6M

% of Portfolio:1.1% ($14.6M/$1.4B)

Inhibikase Therapeutics, Inc.

IKT|45719W205

Shares:5.3M

Value:$11.7M

% of Portfolio:0.9% ($11.7M/$1.4B)

Oric Pharmaceuticals, Inc.

ORIC|68622P109

Shares:2.0M

Value:$11.2M

% of Portfolio:0.8% ($11.2M/$1.4B)

Apogee Therapeutics, Inc.

APGE|03770N101

Shares:290.0K

Value:$10.8M

% of Portfolio:0.8% ($10.8M/$1.4B)

Neurogene Inc.

NGNE|64135M105

Shares:925.0K

Value:$10.8M

% of Portfolio:0.8% ($10.8M/$1.4B)

Tyra Biosciences, Inc.

TYRA|90240B106

Shares:950.0K

Value:$8.8M

% of Portfolio:0.7% ($8.8M/$1.4B)

G70077105

Shares:750.0K

Value:$7.7M

% of Portfolio:0.6% ($7.7M/$1.4B)

Celcuity Inc.

CELC|15102K100

Shares:695.6K

Value:$7.0M

% of Portfolio:0.5% ($7.0M/$1.4B)

Vistagen Therapeutics, Inc.

VTGN|92840H400

Shares:1.6M

Value:$3.9M

% of Portfolio:0.3% ($3.9M/$1.4B)

Avalo Therapeutics, Inc.

AVTX|05338F306

Shares:483.0K

Value:$3.9M

% of Portfolio:0.3% ($3.9M/$1.4B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Cardiff Oncology, Inc.(CRDFcusip14147L108)	5.4M	QoQ 0.00% (-0) YoY NEW(+5.4M)	All Managers (Combined)	$16.9M	1.2% ($16.9M/$1.4B)	QoQ -27.64% (-$6.5M) YoY NEW(+$16.9M)
Oruka Therapeutics, Inc.(ORKAcusip687604108)	1.4M	QoQ 0.00% (-0) YoY NEW(+1.4M)	All Managers (Combined)	$14.6M	1.1% ($14.6M/$1.4B)	QoQ -47.08% (-$13.0M) YoY NEW(+$14.6M)
Inhibikase Therapeutics, Inc.(IKTcusip45719W205)	5.3M	QoQ -9.79% (-580.6K) YoY NEW(+5.3M)	All Managers (Combined)	$11.7M	0.9% ($11.7M/$1.4B)	QoQ -39.21% (-$7.6M) YoY NEW(+$11.7M)
Oric Pharmaceuticals, Inc.(ORICcusip68622P109)	2.0M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$11.2M	0.8% ($11.2M/$1.4B)	QoQ -30.85% (-$5.0M) YoY -59.41% (-$16.3M)
Apogee Therapeutics, Inc.(APGEcusip03770N101)	290.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$10.8M	0.8% ($10.8M/$1.4B)	QoQ -17.52% (-$2.3M) YoY -43.77% (-$8.4M)
Neurogene Inc.(NGNEcusip64135M105)	925.0K	QoQ +15.62% (-125.0K) YoY +362.50% (+725.0K)	All Managers (Combined)	$10.8M	0.8% ($10.8M/$1.4B)	QoQ -40.77% (-$7.5M) YoY +6.40% (+$651.8K)
Tyra Biosciences, Inc.(TYRAcusip90240B106)	950.0K	QoQ NEW(+950.0K) YoY NEW(+950.0K)	All Managers (Combined)	$8.8M	0.7% ($8.8M/$1.4B)	QoQ NEW(+$8.8M) YoY NEW(+$8.8M)
(cusipG70077105)✕	750.0K	QoQ 0.00% (+0) YoY NEW(+750.0K)	All Managers (Combined)	$7.7M	0.6% ($7.7M/$1.4B)	QoQ +1.17% (+$90.0K) YoY NEW(+$7.7M)
Celcuity Inc.(CELCcusip15102K100)	695.6K	QoQ +73.91% (+295.6K) YoY -55.29% (-860.3K)	All Managers (Combined)	$7.0M	0.5% ($7.0M/$1.4B)	QoQ +34.32% (+$1.8M) YoY -79.07% (-$26.6M)
Vistagen Therapeutics, Inc.(VTGNcusip92840H400)	1.6M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$3.9M	0.3% ($3.9M/$1.4B)	QoQ -15.25% (-$708.8K) YoY -52.65% (-$4.4M)
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	483.0K	QoQ 0.00% (+0) YoY NEW(+483.0K)	All Managers (Combined)	$3.9M	0.3% ($3.9M/$1.4B)	QoQ +7.80% (+$280.1K) YoY NEW(+$3.9M)